Clinical Trials Directory

Trials / Completed

CompletedNCT04699890

Development of Specific Diagnostic Tools for Cardiac Insufficiency With Preserved Ejection Fraction

Status
Completed
Phase
Study type
Observational
Enrollment
91 (actual)
Sponsor
University Hospital, Montpellier · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

The MeDIAGSTOLE project aims to develop diagnostic tools for heart failure with preserved ejection fraction (IC / FEp), a pathology that is difficult to diagnose and to manage clinically in the absence of targeted treatment . The IC / FEp concerns the elderly population with comorbidities such as hypertension, obesity, anemia and atrial fibrillation. In the absence of specific biomarkers, clinical diagnosis is based on serum markers of heart failure with reduced ejection fraction (IC / FEr). The identification of new biomarkers, genetic and / or cellular, specific for IC / FEp would be an important innovation.

Conditions

Interventions

TypeNameDescription
OTHERBlood sampling, questionnaires and specific examsPatients will have additionnal blood samples, answer to self-questionnaires and will performed an electrocardiogram and an echocardiography if not performed in routine care.

Timeline

Start date
2022-01-11
Primary completion
2025-01-31
Completion
2025-01-31
First posted
2021-01-07
Last updated
2025-09-30

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04699890. Inclusion in this directory is not an endorsement.

Development of Specific Diagnostic Tools for Cardiac Insufficiency With Preserved Ejection Fraction (NCT04699890) · Clinical Trials Directory